In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

AstraZeneca and Sanofi answered some questions about the approval of RSV drug Beyfortus for our newsletter on children's diseases.

Related Keywords

United States ,Tonya Villafana ,Jon Heinrichs ,Sanofi Beyfortus ,Louis Bont ,Research Group ,University Medical Center Utrecht ,Astrazeneca ,European Union ,Sanofi Alliance ,European Commission ,Swedish Orphan Biovitrum ,Biologics License Application ,